ELECTROPHYSIOLOGY TRANSFORMING ARTRIAL FIBRILLATION TREATMENT.
Technological innovation in EP catheter ablation, coupled with strong clinical outcomes, have resulted in increased physician recognition of EP catheter ablation as a viable option for treating AF patients, facilitating very rapid US procedure and market growth. Advances in EP catheter technology have enabled more accurate diagnoses and targeted therapies, while strong clinical outcomes have convinced physicians of the safety and efficacy of EP catheter ablation for AF treatment. The combination of increased physician recognition and benefits from innovative technological advancement will drive the market through 2012.
MRG also publishes quarterly publications on the orthopedics (OrthoIQ), aesthetics (AestheticsIQ), endoscopy, urology & gynecology (EndoIQ), and imaging and IT markets (ImagingIQ).
About Millennium Research Group
Millennium Research Group (http://www.mrg.net/), a Decision Resources, Inc. company (http://www.decisionresources.com/), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized consulting services.
For more information, visit http://www.mrg.net or call 416/364-7776, ext. 101.
|Printer friendly Cite/link Email Feedback|
|Publication:||Biotech Equipment Update|
|Date:||Sep 1, 2008|
|Previous Article:||ORBUSNEICH ADDS SAPHHIRE NC CORONARY DILATATION CATHETER.|
|Next Article:||RIVERAING WINS COMPUTER-AIDED DETECTION CONTRACT.|